Molecular remission with arsenic trioxide in acute promyelocytic leukemia: Indian APL [acute promyelocytic leukaemia] Study Group – IAPLSG
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 12 Dec 2011 Status changed from recruiting to completed.
- 12 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
- 28 Aug 2007 New trial record.